Search

everythinglearnresearchcommunity

for

Search:↓

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Ginsenoside F2 may help prevent hair loss and promote hair growth better than finasteride.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

Id proteins, especially Id2 and Id3, are crucial for hair follicle development and stem cell regulation.

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

Aryl hydrocarbon receptor overexpression found in miniaturized hair follicles in female hair loss.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

Genetically modified cells can regenerate skin and hair in rats.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.

The document concludes that MGRN1 affects mouse fur color by interfering with a receptor's signaling, but its full role in the body is still unknown.

RPGRIP1L helps skin cells stick together by blocking PKCβII, which can prevent skin blistering like in pemphigus.

The B2 genes are crucial for hair growth in rats.

The rs1128977 gene variant may affect cholesterol and body measurements.

Women with hair loss had lower IGF-1 levels.

Removing GRK2 in skin cells causes hair loss similar to immune-related alopecia.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

S100A4 and NMIIA promote tumor growth in glioblastoma by enhancing blood vessel functions.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

FGF-9 speeds up the early development of certain organs, showing potential for organ regeneration.

Inhibiting EGFR weakens skin's defense against bacteria.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Frizzled 3 and Frizzled 6 together control the orientation of mouse hair follicles.

Reducing gefitinib dosage improved hair loss, but scarring remained.